[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
October 13, 2010

Ghost Busting

JAMA. 2010;304(14):1546. doi:10.1001/jama.2010.1416

Senate Finance Committee leaders have responded to complaints by the chair of the American Heart Association's (AHA’s) Scientific Publishing Committee that they had unfairly singled out the AHA's journal, Circulation, for publishing a ghostwritten article (Haffner SM et al. Circulation. 2002;106[6]:679-684). The 2002 article touted the benefits of rosiglitazone for lowering levels of certain biomarkers for cardiovascular risk in patients with type 2 diabetes.

First Page Preview View Large
First page PDF preview
First page PDF preview
×